From a general standpoint, all immune infiltrated models (RENCA, EMT6, and CT26) exhibit immune population loss with increasing tumor size, suggesting that the tumor can outgrow the infiltrates or prevent further influx of immune cells. This evidence concerns the gene DDX53 and neoplasm.